Cancellation of state registration. Lorista®

February 27, 2018
Active substances:
Trade names:
ICD-10:
IX.I10-I15.I10    Essential [primary] hypertension
IX.I30-I52.I50.0    Congestive heart failure
Lorist, losartan, arterial hypertension, treatment of arterial hypertension, chronic heart failure

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state registermedicinal products for the medical use of the medicinal product (registration certificate LP-003683 dated 16.06.2016 issued by Krka-Rus, Russia):

Lorista® (trade name of the medicinal product)

Losartan (international non-proprietary or chemical name of the medicinal product)

film-coated tablets, 150 mg (dosage form, dosage)

Limited Liability Company "KRKA-RUS" (LLC "KRKA-RUS"), Russia 143500, Moscow Region, Istra, ul. Moscow, 50 (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the owner of the registration certificate of OOO KRKA-RUS, Russia, an application for the cancellation of the state registration of a medicinal product.